Bone Marrow TransplantationTransplantation, AutologousBone MarrowTransplantation, HomologousBone Marrow CellsHematopoietic Stem Cell TransplantationGraft vs Host DiseaseWhole-Body IrradiationStem Cell TransplantationTransplantation ConditioningBone and BonesBone Marrow PurgingCombined Modality TherapyAnemia, AplasticHematopoietic Stem CellsLeukemiaCyclophosphamideBusulfanGraft SurvivalTransplantation ChimeraLiver TransplantationRemission InductionMelphalanTissue DonorsTreatment OutcomeMultiple MyelomaRecurrenceStem CellsHistocompatibility TestingAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Non-HodgkinHistocompatibilityTransplantation, IsogeneicHematopoiesisBone Marrow DiseasesKidney TransplantationPeripheral Blood Stem Cell TransplantationCarmustineLeukemia, Myeloid, AcuteTime FactorsEtoposideHematologic NeoplasmsMice, Inbred C57BLCytarabineDisease-Free SurvivalSurvival AnalysisHodgkin DiseaseRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressive AgentsBone Marrow ExaminationRetrospective StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, MyeloidSalvage TherapySurvival RateGraft RejectionHepatic Veno-Occlusive DiseaseBone RemodelingHematopoietic Stem Cell MobilizationAcute DiseaseTransplantation ImmunologyBone Marrow NeoplasmsT-LymphocytesGraft vs Host ReactionMyelodysplastic SyndromesImmunosuppressionFollow-Up StudiesLymphocyte DepletionLeukocyte TransfusionGranulocyte Colony-Stimulating FactorColony-Forming Units AssayThiotepaHeart TransplantationVincristineAntigens, CD34LymphomaHLA AntigensChimeraSevere Combined ImmunodeficiencyPrognosisCell DifferentiationActuarial AnalysisHematologic DiseasesLung TransplantationLymphocyte TransfusionCyclosporineCells, CulturedBone DensityLeukocyte CountFlow CytometryMyeloablative AgonistsGraft vs Tumor EffectNuclear FamilyOrgan TransplantationPancytopeniaFatal OutcomeGraft vs Leukemia EffectCytomegalovirus InfectionsPodophyllotoxin